Key terms

About LRMR

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LRMR news

Apr 03 9:14am ET Leerink bullish on Larimar Therapeutics, initiates with an Outperform by TipRanks Apr 03 8:02am ET Larimar Therapeutics initiated with an Outperform at Leerink by TipRanks Mar 18 8:35am ET 5 Stocks that Analysts Love in March 2024 by TipRanks Mar 15 4:15pm ET Buy Rating Justified: Larimar Therapeutics’ Advancements Towards FDA Approval for FA Drug Nomlabofusp by TipRanks Mar 14 4:21pm ET Larimar Therapeutics provides update on nomlabofusp development by TipRanks Mar 14 4:18pm ET Larimar Therapeutics reports Q4 EPS (30c), consensus (25c) by TipRanks Mar 12 8:25am ET Buy Rating on Larimar Therapeutics Backed by Promising Drug Progress for Friedreich’s Ataxia by TipRanks Mar 12 6:09am ET 3 Best Stocks to Buy Now, 3/12/2024, According to Top Analysts by TipRanks Mar 12 12:40am ET Analysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Larimar Therapeutics (LRMR) by TipRanks Mar 11 4:26pm ET Larimar Therapeutics doses first patient in nomlabofusp study by TipRanks Mar 05 8:45am ET Largest borrow rate increases among liquid names by TipRanks Feb 20 7:55pm ET Buy Rating Affirmed: Larimar Therapeutics’ Nomlabofusp Shows Potential in Friedreich’s Ataxia Treatment by TipRanks Feb 19 2:08am ET Insider Trading: Larimar’s (NASDAQ:LRMR) Director Makes an Enormous Purchase by TipRanks Feb 16 4:27pm ET Larimar Therapeutics Secures $161.8M from Public Offering by TipRanks Feb 14 6:19am ET Larimar Therapeutics 17.2M share Spot Secondary priced at $8.74 by TipRanks Feb 13 4:23pm ET Larimar Therapeutics files common stock, warrants offering by TipRanks Feb 13 5:08am ET Buy Rating Affirmed on Larimar Therapeutics Amid Promising Clinical Trial Results and Accelerated Approval Pathway by TipRanks Feb 13 4:59am ET Buy Rating Affirmed: Larimar Therapeutics’ Promising Drug Advances on Regulatory and Efficacy Fronts by TipRanks Feb 12 7:03pm ET Larimar Therapeutics price target raised to $10 from $4.50 at Citi by TipRanks Feb 12 8:24am ET Larimar Therapeutics Announces Successful Phase 2 Nomlabofusp Study by TipRanks Feb 12 8:12am ET Larimar Therapeutics Reports Positive Phase 2 Results, Updates Investor Resources by TipRanks Feb 12 8:09am ET Larimar Therapeutics Phase 2 Success in Friedreich’s Ataxia Trial by TipRanks Feb 12 7:13am ET Larimar Therapeutics expects cash to provide runway into 1Q25 by TipRanks Feb 12 7:12am ET Larimar reports topline data from Phase 2 dose exploration study of nomlabofusp by TipRanks Jan 31 2:50pm ET William Blair biotech analyst to hold an analyst/industry conference call by TipRanks Jan 31 4:55am ET William Blair biotech analyst to hold an analyst/industry conference call by TipRanks Jan 30 12:44pm ET William Blair biotech analyst to hold an analyst/industry conference call by TipRanks

No recent press releases are available for LRMR

LRMR Financials

1-year income & revenue

Key terms

LRMR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LRMR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming